Multicenter prospective blinded melanoma detection study with a handheld elastic scattering spectroscopy device.

Rebecca I Hartman1,2,3, Nicole Trepanowski1,4, Michael S Chang1,2

  • 1Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

JAAD International
|February 19, 2024
PubMed
Summary

The elastic scattering spectroscopy (ESS) device shows high sensitivity (95.5%) for detecting melanoma, making it a promising tool for early skin cancer diagnosis. Its high negative predictive value (98.1%) is particularly useful for ruling out melanoma.

Related Concept Videos